Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32219702)

  • 1. The role of ErbB4 in cancer.
    Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
    Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.
    Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.
    Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M
    Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling.
    Wandinger SK; Lahortiga I; Jacobs K; Klammer M; Jordan N; Elschenbroich S; Parade M; Jacoby E; Linders JT; Brehmer D; Cools J; Daub H
    PLoS One; 2016; 11(1):e0146100. PubMed ID: 26745281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
    Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
    BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells.
    Kornblum HI; Yanni DS; Easterday MC; Seroogy KB
    Dev Neurosci; 2000; 22(1-2):16-24. PubMed ID: 10657694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
    Haskins JW; Nguyen DX; Stern DF
    Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation.
    Hoesl C; Röhrl JM; Schneider MR; Dahlhoff M
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):958-966. PubMed ID: 29410073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of regulatory mechanism after ErbB4 gene mutation based on local modeling methodology.
    Chen CL; Zhao JW
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
    Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
    Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ErbB4 in breast cancer.
    Sundvall M; Iljin K; Kilpinen S; Sara H; Kallioniemi OP; Elenius K
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):259-68. PubMed ID: 18454307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles.
    Fock V; Plessl K; Fuchs R; Dekan S; Milla SK; Haider S; Fiala C; Knöfler M; Pollheimer J
    Hum Reprod; 2015 Apr; 30(4):789-99. PubMed ID: 25740878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the four isoforms of receptor tyrosine kinase ErbB4, but not ErbB1, confers cardiomyocyte hypertrophy.
    Wang Z; Chan HW; Gambarotta G; Smith NJ; Purdue BW; Pennisi DJ; Porrello ER; O'Brien SL; Reichelt ME; Thomas WG; Paravicini TM
    J Cell Physiol; 2021 Dec; 236(12):8160-8170. PubMed ID: 34170016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations of the ERBB4 kinase domain in human cancers.
    Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.